INTELLIGENT BIO SOLUTIONS INC. — Director's Dealing 2022

Dec 23, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK: 0001725430
Period of Report: 2022-12-22

Reporting Person: Sakiris Spiro Kevin (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-12-22	Series D Convertible Preferred Stock	$	P	15992	Acquired		Common Stock (15993)	Indirect
2022-12-22	Common Stock Purchase Warrant	$0.29	P	47979	Acquired	2028-06-23	Common Stock (47979)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock - Prior Balance	125228	Direct

Footnotes

F1: The Series D Convertible Preferred Stock is initially convertible into three shares of common stock of the Issuer. The conversion ratio is subject to adjustment. Following the Trigger Date (defined below), each share of Series D Convertible Preferred Stock is convertible at any time at the option of the holder and without payment of further consideration. The Series D Convertible Preferred Stock has no expiration date. As used herein, "Trigger Date" means the earlier to occur of (i) the date that the last of (a) the Issuer's shareholders approve the conversion of the Series D Convertible Preferred Stock or (b) the Issuer's shareholders approve a reverse split of the Issuers's common stock, or (ii) the date which is 60 days following the date on which the Common Stock is no longer listed on the Nasdaq Stock Market, the New York Stock Exchange or the NYSE American.

F2: On December 22, 2022, Anest Holdings Pty Ltd, as trustee of ATF S&T Sakiris Superannuation Fund, purchased 15,993 units from the Issuer in a private placement. Each unit consists of one share of Series D Convertible Preferred Stock (valued at $0.87 each) and three common stock purchase warrants (collectively valued at $0.35, or $0.1267 each). The purchase price of each unit was $1.25 per unit.

F3: These securities are held by Anest Holdings Pty Ltd, as trustee of ATF S&T Sakiris Superannuation Fund, of which Mr. Sakiris is a Director.

F4: Subject to adjustment.